Company
IsraelPublic company, NYSE: TEVATeva Pharmaceutical Industries (NYSE: TEVA), Jerusalem, Israel – FDA Inspections
Inspection records and compliance data for Teva Pharmaceutical Industries in Jerusalem. 4 FDA inspections on record (1 OAI), 1 Form 483, last inspected August 01, 2019. Publicly traded as NYSE: TEVA.
Company Profile
This profile covers Teva Pharmaceutical Industries based in Jerusalem, Israel.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 1
- VAI
- 2
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected September 16, 2010. Last inspected August 1, 2019.
Most cited issue areas
- Batch production and Batch Control Record Requirements1 inspection
- Procedures To Be in Writing1 inspection
- SOPs not followed / documented1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 1, 2019 | VAI | Human Drugs · Drug Quality Assurance | 1101325 |
| June 22, 2015 | VAI | Human Drugs · Drug Quality Assurance | 935714 |
| June 19, 2011 | NAI | Human Drugs · Drug Quality Assurance | 733882 |
| September 16, 2010 | OAI | Human Drugs · Drug Quality Assurance | 695835 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Teva Pharmaceutical Industries
Stock ticker
TEVA
Exchange
NYSE
Share price
$43.65
Market cap
$50.9B
Price as of
November 13, 2026
FEI Number
3005202697
Address
Har Hozvim, 20, Kiryat HaMada Street, Jerusalem, Israel
Country
Israel
ID: bfd30c7f-d1d9-4c7b-b7c8-57285b9615c2